← FDA Drug Approvals (Drugs@FDA)

SYFOVRE

NDA · New Drug Application · Sponsor: APELLIS PHARMS · Approved 2023-02-17

Drug application

FDA Application #

NDA217171

Application type

New Drug Application

Brand name

SYFOVRE

Generic name

PEGCETACOPLAN

Active ingredients

PEGCETACOPLAN

Dosage form

SOLUTION

Route

INTRAVITREAL

Marketing status

Prescription

Sponsor

APELLIS PHARMS

Manufacturer

Apellis Pharmaceuticals, Inc.

First approval

2023-02-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown